Scilex Holding (SCLX) Accumulated Expenses (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Accumulated Expenses of $247.5 million for Q1 2026, up 14863.72% year-over-year from N/an in Q1 2025, and up 7468.81% on a QoQ basis from $3.3 million in Q4 2025.

Scilex Holding (SCLX) Accumulated Expenses (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Accumulated Expenses for 6 consecutive years, with $247.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 14863.72% year-over-year to $247.5 million; the TTM figure through Mar 2026 stood at $247.5 million (up 14863.72% YoY), while the FY2025 annual figure was $3.3 million, down 97.99% from the prior year.
  • Accumulated Expenses came in at $247.5 million for Q1 2026 at Scilex Holding, up from $3.3 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $247.5 million in Q1 2026, with the low at $500000.0 in Q1 2024.
  • Average Accumulated Expenses over 5 years is $33.4 million, with a median of $2.7 million recorded in 2023.
  • Across the five-year window, Accumulated Expenses sank 97.99% in 2025 and surged 14863.72% in 2026, its largest moves.
  • Year by year, Accumulated Expenses stood at $1.4 million in 2022, then jumped by 98.01% to $2.7 million in 2023, then jumped by 5961.17% to $162.5 million in 2024, then tumbled by 97.99% to $3.3 million in 2025, then jumped by 7468.81% to $247.5 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $247.5 million, $3.3 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 247.50 Mn
Dec 31, 2025 3.27 Mn
Sep 30, 2025 2.95 Mn
Jun 30, 2025 1.63 Mn
Mar 31, 2025 1.65 Mn
Dec 31, 2024 162.50 Mn
Jun 30, 2024 4.07 Mn
Mar 31, 2024 500,000.00
Dec 31, 2023 2.68 Mn
Sep 30, 2023 1.92 Mn
Jun 30, 2023 2.75 Mn
Mar 31, 2023 1.71 Mn
Dec 31, 2022 1.35 Mn
Dec 31, 2021 3.73 Mn